Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing

Steven E. Conklin, Kathryn Martin, Yukari C Manabe, Haley A Schmidt, Jernelle Miller, Morgan Keruly, Ethan Klock, Charles S Kirby, Owen R Baker, Reinaldo E Fernandez, Yolanda J Eby, Justin Hardick, Kathryn Shaw-Saliba, Richard E Rothman, Patrizio P Caturegli, Andrew R Redd, Aaron AR Tobian, Evan M Bloch, H Benjamin Larman, Thomas C Quinn, William Clarke, Oliver Laeyendecker
doi: https://doi.org/10.1101/2020.07.31.20166041
Steven E. Conklin
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Martin
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukari C Manabe
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haley A Schmidt
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jernelle Miller
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morgan Keruly
cDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ethan Klock
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles S Kirby
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Owen R Baker
cDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinaldo E Fernandez
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda J Eby
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Hardick
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Shaw-Saliba
dDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard E Rothman
dDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizio P Caturegli
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew R Redd
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
cDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron AR Tobian
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan M Bloch
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Benjamin Larman
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C Quinn
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
cDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Clarke
aDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Laeyendecker
bDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
cDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: olaeyen1@jhmi.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Rapid point-of-care tests (POCTs) for SARS-CoV-2-specific antibodies vary in performance. A critical need exists to perform head-to-head comparison of these assays.

Methods Performance of fifteen different lateral flow POCTs for the detection of SARS-CoV-2-specific antibodies was performed on a well characterized set of 100 samples. Of these, 40 samples from known SARS-CoV-2-infected, convalescent individuals (average of 45 days post symptom onset) were used to assess sensitivity. Sixty samples from the pre-pandemic era (negative control), that were known to have been infected with other respiratory viruses (rhinoviruses A, B, C and/or coronavirus 229E, HKU1, NL63 OC43) were used to assess specificity. The timing of seroconversion was assessed on five POCTs on a panel of 272 longitudinal samples from 47 patients of known time since symptom onset.

Results For the assays that were evaluated, the sensitivity and specificity for any reactive band ranged from 55%-97% and 78%-100%, respectively. When assessing the performance of the IgM and the IgG bands alone, sensitivity and specificity ranged from 0%-88% and 80%-100% for IgM and 25%-95% and 90%-100% for IgG. Longitudinal testing revealed that median time post symptom onset to a positive result was 7 days (IQR 5.4, 9.8) for IgM and 8.2 days (IQR 6.3 to 11.3).

Conclusion The testing performance varied widely among POCTs with most variation related to the sensitivity of the assays. The IgM band was most likely to misclassify pre-pandemic samples. The appearance of IgM and IgG bands occurred almost simultaneously.

Competing Interest Statement

Evan M Bloch is a member of the United States Food and Drug Administration Blood Products Advisory Committee.

Funding Statement

The study was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Research reported in this publication was supported research awards: NIAID, [UM1-AI068613 R01AI120938 and R01AI128779]; National Institute of Biomedical Imaging and Bioengineering [U54EB007958]; National Heart, Lung, and Blood Institute of the National Institutes of Health [K23HL151826 and 1K23HL151826-01]. Work was supported in part by the NIAID Contract HHSN272201400007C awarded to the Johns Hopkins Center for Influenza Research and Surveillance (JHCEIRS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The parent studies were approved by The Johns Hopkins University School of Medicine Institutional Review Board (IRB00247886, IRB00250798 and IRB00091667). All samples were de-identified prior to testing. The parent studies were conducted according to the ethical standards of the Helsinki Declaration of the World Medical Association. This report includes an analysis of stored samples and data from those studies. No additional samples were collected for the current study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available from the corresponding author upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing
Steven E. Conklin, Kathryn Martin, Yukari C Manabe, Haley A Schmidt, Jernelle Miller, Morgan Keruly, Ethan Klock, Charles S Kirby, Owen R Baker, Reinaldo E Fernandez, Yolanda J Eby, Justin Hardick, Kathryn Shaw-Saliba, Richard E Rothman, Patrizio P Caturegli, Andrew R Redd, Aaron AR Tobian, Evan M Bloch, H Benjamin Larman, Thomas C Quinn, William Clarke, Oliver Laeyendecker
medRxiv 2020.07.31.20166041; doi: https://doi.org/10.1101/2020.07.31.20166041
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing
Steven E. Conklin, Kathryn Martin, Yukari C Manabe, Haley A Schmidt, Jernelle Miller, Morgan Keruly, Ethan Klock, Charles S Kirby, Owen R Baker, Reinaldo E Fernandez, Yolanda J Eby, Justin Hardick, Kathryn Shaw-Saliba, Richard E Rothman, Patrizio P Caturegli, Andrew R Redd, Aaron AR Tobian, Evan M Bloch, H Benjamin Larman, Thomas C Quinn, William Clarke, Oliver Laeyendecker
medRxiv 2020.07.31.20166041; doi: https://doi.org/10.1101/2020.07.31.20166041

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1752)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (657)
  • Epidemiology (10792)
  • Forensic Medicine (8)
  • Gastroenterology (586)
  • Genetic and Genomic Medicine (2939)
  • Geriatric Medicine (287)
  • Health Economics (532)
  • Health Informatics (1921)
  • Health Policy (835)
  • Health Systems and Quality Improvement (745)
  • Hematology (291)
  • HIV/AIDS (628)
  • Infectious Diseases (except HIV/AIDS) (12510)
  • Intensive Care and Critical Care Medicine (687)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2791)
  • Nursing (151)
  • Nutrition (432)
  • Obstetrics and Gynecology (558)
  • Occupational and Environmental Health (597)
  • Oncology (1460)
  • Ophthalmology (443)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (363)
  • Primary Care Research (336)
  • Psychiatry and Clinical Psychology (2636)
  • Public and Global Health (5350)
  • Radiology and Imaging (1009)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)